Search
Search Results
##search.searchResults.foundPlural##
-
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3692PDF: 1430HTML: 465Figures . Eliassian: 207 -
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
710PDF: 455HTML: 6249 -
Refractory Immune Thrombocytopenic Purpura and Cytomegalovirus Infection: A Call for a Change in the Current Guidelines
4185PDF: 1145HTML: 2128Figure 1: 152 -
DEMOGRAPHICAL, VIRO-IMMUNOLOGICAL, CLINICAL AND THERAPEUTICAL CHARACTERISTICS OF HIV INFECTED PATIENTS IN A “EPIDEMIOLOGICALLY UNEXPLORED” REGION OF ITALY (CALABRIA REGION): THE CALABRHIV COHORT.
1569PDF: 772HTML: 1220Figure 1: 157Figure 2: 173Figure 3: 168 -
Cardiac toxicity associated with HCV direct antiviral agents Heart in HCV DAAs therapy
1519PDF: 951HTML: 165 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4378PDF: 1884HTML: 17714 -
Acute Cytomegalovirus infection as a cause of venous thromboembolism
1537PDF: 830HTML: 1023Picture 1: 156 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3161PDF: 979HTML: 1992 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
7743PDF: 4018HTML: 7304 -
A HEALTH RELATED QUALITY OF LIFE AND PSYCHOPATHOLOGICAL SYMPTOMS IN PEOPLE WITH HEMOPHILIA, BLOODBORNE CO-INFECTIONS AND COMORBIDITIES: AN ITALIAN MULTICENTER OBSERVATIONAL STUDY PSYCHOLOGICAL DINAMICS OF A GROUP OF ITALIAN HEMOPHILIACS WITH AND WITHOUT (CO)INFECTIONS AND COMORBIDITIES: A MULTICENTER STUDY
1383PDF: 1182HTML: 487 -
LYMPHOCYTES IN PATIENTS WITH CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1 EXPRESSION AND A PREVAILING TH2 IMMUNE RESPONSE. EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1
2576PDF: 1056HTML: 99 -
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1223PDF: 458HTML: 18550Figure 1: 154Figure 2: 138Figure 3: 156Figure 4: 188Figure 5: 160 -
Guest Editor: G. Castaman AGING WITH HEMOPHILIA: THE CHALLENGE OF APPROPRIATE DRUG PRESCRIPTION Hemophilia and aging
1625PDF: 1417HTML: 235 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4023PDF: 1545HTML: 873 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2451PDF: 823HTML: 8795Efremov 1: 208Efremov 2: 170 -
GLUCOSE HOMEOSTASIS AND ΑSSESSMENT OF Β-CELL FUNCTION BY 3-HOUR ORAL GLUCOSE TOLERANCE (OGTT) IN PATIENTS WITH Β-THALASSEMIA MAJOR WITH SERUM FERRITIN BELOW 1,000 NG/DL: RESULTS FROM A SINGLE ICET-A CENTRE OGTT in thalassemia and iron overload
3835PDF: 1074HTML: 414 -
APPROACHING THE TARGET: THE PATH TOWARDS AN EFFECTIVE MALARIA VACCINE
2495PDF: 929HTML: 15081 -
Seroprevalence of transfusion-transmissible infections among family replacement donors and voluntary non-remunerated blood donors during the COVID-19 pandemic in sub Saharan Africa family replacement donors and voluntary non-remunerated blood donors in transfusion transmissible infections
1517PDF: 1241HTML: 128 -
Epstein-Barr Virus (EBV)-associated Haemophagocytic Syndrome
1779PDF: 812HTML: 1557 -
Editorial : INTRODUCING MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
3270PDF: 566HTML: 636 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1348PDF: 802HTML: 3104







